Advanced search
Publication Cover
Leukemia & Lymphoma Volume 9, 1993 - Issue 1-2
Submit an article Journal homepage
21
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Long-Term Treatment of Chronic Myelogenous Leukemia with Different Interferons: Results from Three Studies

Norbert Niederle Städt. Krankenhaus, Dhünnberg 60, D-5090, Leverkusen, FRG
,
Otto Kloke Innere Klinik und Poliklinik Tumorforschung, Westdeutsches Tumorzentrum
,
Ursula B. Wandl Innere Klinik und Poliklinik Tumorforschung, Westdeutsches Tumorzentrum
,
Reinhard Becher Innere Klinik und Poliklinik Tumorforschung, Westdeutsches Tumorzentrum
,
Thomas Moritz Institut für Molekularbiologie Tumorforschung, Essen, Germany
&
Bertram Opalka Institut für Molekularbiologie Tumorforschung, Essen, Germany
Pages 111-119 | Received 20 Jun 1992, Published online: 01 Jul 2009

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Juergen Thiele, Hans Michael Kvasnicka, Robert Fischer & Volker Diehl. (1997) Clinicopathological Impact of the Interaction Between Megakaryocytes and Myeloid Stroma in Chronic Myeloproliferative Disorders: A Concise Update. Leukemia & Lymphoma 24:5-6, pages 463-481.
Read now
Alexandra S. Worobec, Arnold S. Kirshenbaum, Lawrence B. Schwartz & Dean D. Metcalfe. (1996) Treatment of Three Patients with Systemic Mastocytosis with Interferon Alpha-2b. Leukemia & Lymphoma 22:5-6, pages 501-508.
Read now

Articles from other publishers (27)

Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 197 226 .
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 207 230 .
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. (2015) The interferon-alpha revival in CML. Annals of Hematology 94:S2, pages 195-207.
Crossref
A Sharma, H Yun, N Jyotsana, A Chaturvedi, A Schwarzer, E Yung, C K Lai, F Kuchenbauer, B Argiropoulos, K Görlich, A Ganser, R K Humphries & M Heuser. (2014) Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling. Leukemia 29:1, pages 157-168.
Crossref
M Talpaz, R Hehlmann, A Quintás-Cardama, J Mercer & J Cortes. (2012) Re-emergence of interferon-α in the treatment of chronic myeloid leukemia. Leukemia 27:4, pages 803-812.
Crossref
Xin-Yuan Liu, Guang-Wen Wei, Dong-Qin Yang, Lun-Xu Liu, Lin Ma, Xiao Li, Jian OuYang, Cui-Ping Li, Kang-Jian Zhang, Jian Wang, Liang Chu, Jin-Fa Gu, Huang-Guang Li, Jian Ding, Na Wei, Ying Cai, Xin-Ran Liu, Xin Cao, Yi Chen, Zhi-Jiang Wu, Miao Ding & Ming Zuo. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy 617 671 .
Ben X. WangRamtin RahbarEleanor N. Fish. (2011) Interferon: Current Status and Future Prospects in Cancer Therapy. Journal of Interferon & Cytokine Research 31:7, pages 545-552.
Crossref
François Guilhot, Lydia Roy, Pierre-Jean Saulnier & Joëlle Guilhot. (2009) Interferon in chronic myeloid leukaemia: past and future. Best Practice & Research Clinical Haematology 22:3, pages 315-329.
Crossref
Lisa A. Kujawski & Moshe Talpaz. (2007) The role of interferon-alpha in the treatment of chronic myeloid leukemia. Cytokine & Growth Factor Reviews 18:5-6, pages 459-471.
Crossref
François Guilhot, Lydia Roy, Joëlle Guilhot & Fredéric Millot. (2004) Interferon therapy in chronic myelogenous leukemia. Hematology/Oncology Clinics of North America 18:3, pages 585-603.
Crossref
Hans Michael KvasnickaJuergen ThieleAnnette Schmitt-GraeffVolker DiehlRudolf ZankovichNorbert NiederleLutz-Dietrich LederHans Eckart Schaefer. (2001) Bone Marrow Features Improve Prognostic Efficiency in Multivariate Risk Classification of Chronic-Phase Ph 1+ Chronic Myelogenous Leukemia: A Multicenter Trial . Journal of Clinical Oncology 19:12, pages 2994-3009.
Crossref
O Kloke, B Opalka & N Niederle. (2000) Interferon alfa as primary treatment of chronic myeloid leukemia: long-term follow-up of 71 patients observed in a single center. Leukemia 14:3, pages 389-392.
Crossref
R. Kath, W. Aulitzky & K. Höffken. 2000. Kompendium der praktischen Medizin. Kompendium der praktischen Medizin 947 953 .
Taizo Shimomura, Shin‐ichiro Fujii, Ichiko Ezaki, Motomi Osato, Koji Fujimoto, Kiyoshi Takatsuki, Kazuhiko Yamamoto & Makoto Kawakita. (2005) Characterization of T‐cell receptor β chain mRNA expression in IFN‐α‐responsive chronic myelogenous leukaemia patients. British Journal of Haematology 105:1, pages 173-180.
Crossref
Taizo Shimomura, Shin-ichiro Fujii, Ichiko Ezaki, Motomi Osato, Koji Fujimoto, Kiyoshi Takatsuki, Kazuhiko Yamamoto & Makoto Kawakita. (1999) Characterization of T-cell receptor beta chain mRNA expression in IFN-alpha-responsive chronic myelogenous leukaemia patients. British Journal of Haematology 105:1, pages 173-180.
Crossref
JUERGEN THIELE, CLAUDIA WICKENHAUSER, CHRISTOPH NEUWIRTH, HANS-JOERG SCHULZE, UTA FLUCKE, HANS MICHAEL KVASNICKA, PETER BORCHMANN, RAINER KRECH & ROBERT FISCHER. (1998) Effect of IFN-α on Normal Human Hematopoiesis: An Immunohistochemical and Morphometric Study on Trephine Biopsy Specimens. Journal of Interferon & Cytokine Research 18:4, pages 247-253.
Crossref
J. Thiele, H. M. Kvasnicka, T. K. Zirbes, U. Flucke, N. Niederle, L. D. Leder, V. Diehl & R. Fischer. (2009) Impact of clinical and morphological variables in classification and regression tree‐based survival (CART) analysis of CML with special emphasis on dynamic features. European Journal of Haematology 60:1, pages 35-46.
Crossref
N. Niederle & B. Weidmann. 1998. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 216 235 .
Moshe Talpaz, Hagop M. Kantarjian, Susan O'Brien & Razelle Kurzrock. (1997) 7 The M.D. Anderson Cancer Center experience with interferon-α therapy in chronic myelogenous leukaemia. Baillière's Clinical Haematology 10:2, pages 291-305.
Crossref
Juergen Thiele, Thomas Karl Zirbes, Johann Lorenzen, Hans Michael Kvasnicka, Stephan Dresbach, Brian Manich, Lutz Dietrich Leder, Norbert Niederle, Volker Diehl & Robert Fischer. (1997) Apoptosis and proliferation (PCNA labelling) in CML—a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy. The Journal of Pathology 181:3, pages 316-322.
Crossref
Alessandra Ferrajoli, Marco Fizzotti, Anna Marina Liberati & Fausto Grignani. (1996) Chronic myelogenous leukemia: an update on the biological findings and therapeutic approaches. Critical Reviews in Oncology/Hematology 22:3, pages 151-174.
Crossref
JUERGEN THIELE, THOMAS KARL ZIRBES, HANS MICHAEL KVASNICKA, JOHANN LORENZEN, NORBERT NIEDERLE, LUTZ-DIETRICH LEDER & ROBERT FISCHER. (1996) Effect of Interferon Therapy on Bone Marrow Morphology in Chronic Myeloid Leukemia: A Cytochemical and Immunohistochemical Study of Trephine Biopsies. Journal of Interferon & Cytokine Research 16:3, pages 217-224.
Crossref
Meir Wetzler, Hagop Kantarjian, Razelle Kurzrock & Moshe Talpaz. (1995) Interferon-α therapy for chronic myelogenous leukemia. The American Journal of Medicine 99:4, pages 402-411.
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Norbert Niederle, Otto Kloke, Marcus Schmidt, Heiko Lienhard, Thomas Zirbes, Raoul Boris Meuter, Lutz Dietrich Leder & Robert Fischer. (2006) Clinical and histological features retain their prognostic impact under interferon therapy of CML: A pilot study. American Journal of Hematology 50:1, pages 30-39.
Crossref
J. Thiele, H. M. Kvasnicka, N. Niederle, T. K. Zirbes, M. Schmidt, J. Dammasch, B. R. Meuter, L. -D. Leder, O. Kloke, V. Diehl & R. Fischer. (1995) The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML — A comparative morphometric study on sequential trephine biopsies. Annals of Hematology 70:3, pages 121-128.
Crossref
W. E. Aulitzky, C. Peschel, F. Schneller & C. Huber. (1995) Biotherapy of chronic myelogenous leukemia. Annals of Hematology 70:3, pages 113-120.
Crossref
N. Niederle & B. Weidmann. 1995. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 155 169 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.